respiratory

News

Update: Carlyle baulks at Vectura auction, urges shareholder...

Private equity group Carlyle has said it won't raise its offer for respiratory drug specialist Vectura to match a 165p per share offer from tobacco giant Philip Morris International (PMI).<

News

Update: Bidding war breaks out for respiratory specialist Ve...

A flurry of new offers by Philip Morris International (PMI) and private equity firm Carlyle has hiked the value of respiratory medicines company Vectura to £1 more than a billion ($1.4 bill

News

Sonde Health partners with Qualcomm on vocal biomarker tech

Sonde Health has joined forces with chipmaker Qualcomm to develop a technology platform that could diagnose human health conditions from a short sample of speech.

News

Big tobacco's PMI makes another pharma foray with Vectura de...

Tobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up its recent acquisition of Fertin Pharma with a deal to buy Vectura

News

Nebuliser being filled. Copyright Vectura (002)

Vectura agrees $1.4bn takeover by private equity group Carly...

Vectura has agreed to a £1.55 per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 billion).

News